Limburg Ventures, which was set up by Netherlands-based industrial group DSM and a regional development agency, has backed a €2m ($2.9m) fundraising by health food company BioActor.   Limburg was joined by Nedermaas Ventures, a subsidiary of the Limburg Development and Investment Company, and venture capital firm Icos Capital investing in the series A round. BioActor makes healthy ingredients for dietary supplements and foods. The funding round will be used to launch its first product Bonolive, a bone health ingredient, as well as to to finance other clinical studies for future products. BioActor has relationships with various nutrition research institutes, INRA, CSIC, Maastricht University, UCL and Ghent University. Marcel Kloosterman, investment manager of Limburg Ventures, said he was impressed by the progress Bioactor was making in health claims with regulatory authorities for its portfolio of products. Bioactor was founded in 2005.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.

Not sure if you have a subscription?